Michael Schlenk New Chief Executive Officer of Centogene Holding AG
Centogene Holding AG (formerly Arcensus AG) announced that Michael Schlenk, former CEO of ProBioGen AG joined the management as Chief Executive Officer effective January 2011. He also invested and became a major shareholder.
Michael Schlenk, Chief Executive Officer of Centogene Holding AG.
In addition to many years as management consultant in the area of technology transfer Michael Schlenk has more than 20 years of international life science experience. Before he successfully sold ProBioGen AG, a Biotechnology company from Berlin, in 2010 to the Egyptian healthcare company Minapharm, he worked in Brazil, Austria, the US, Thailand, Switzerland for multinational companies like Abbott and Novartis (formerly Sandoz) as President, General Manager and Area Manager. He graduated as Diplom-Kaufmann from the University of Hamburg, Germany and later earned his M.B.A. Degree from University of Bradford Management Centre, U.K.
Besides his responsibilities for the overall corporate development Michael Schlenk will actively drive Centogene’s international expansion through partnerships and collaborations.
Other news from the department people
